Marco Pravetoni

24PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targetsGene and molecular therapyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jan 27, 2025
A cationic liposome-formulated Toll Like Receptor (TLR)7/8 agonist enhances the efficacy of a vaccine against fentanyl toxicity.

Fatima A Hamid, Nguyet-Minh Nguyen Le, Daihyun Song

|Oct 11, 2024
NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children.

Jenna K Dick, Jules A Sangala, Venkatramana D Krishna

|Jul 17, 2024
Monoclonal Antibodies Engineered with Fc Region Mutations to Extend Protection against Fentanyl Toxicity.

Aaron Khaimraj, Carly A Baehr, Dustin Hicks

|Jul 01, 2024
ACE2 decoy Fc-fusions and bi-specific killer engager (BiKEs) require Fc engagement for in vivo efficacy against SARS-CoV-2.

Jenna K Dick, Dustin Hicks, Venkatramana D Krishna

|Apr 25, 2024
Antibody-mediated cellular responses are dysregulated in Multisystem Inflammatory Syndrome in Children (MIS-C).

Jenna K Dick, Jules A Sangala, Venkatramana D Krishna

|Mar 20, 2023
IL-4 Predicts the Efficacy of a Candidate Antioxycodone Vaccine and Alters Vaccine-Specific Antibody-Secreting Cell Proliferation in Mice.

Bethany Crouse, Carly Baehr, Dustin Hicks

Pageof 4